Neuroglial Pathophysiology of Leukodystrophies
- PMID: 40500501
- DOI: 10.1007/978-3-031-87919-7_10
Neuroglial Pathophysiology of Leukodystrophies
Abstract
Leukodystrophies are a diverse group of inherited diseases characterised by white matter degenerative pathology. Leukodystrophies have a highly heterogeneous genetic background linked mainly to mutations in oligodendrocyte and astrocyte genes and, to lesser extent, microglia. The most prevalent leukodystrophies are caused by mutations in oligodendrocyte genes that encode the essential myelin proteins PLP1 and GalC in Pelizaeus-Merzbacher disease and Krabbe disease, respectively. Astrocyte leukodystrophies are led by Alexander disease, caused by mutations in the astrocyte gene GFAP. Vanishing white matter disease, the most prevalent inherited white matter pathology in children, is associated with astrocyte atrophy and cystic degeneration of the cerebral white matter. The pathogenic mechanisms in leukodystrophies depend on the genetic mutations and hence are extremely varied, but the diseases have in common white matter atrophy caused by the loss of oligodendrocytes and myelin, with or without marked reactive astrogliosis and microglia activation. The development of a range of animal models with the disruption of specific genes causing leukodystrophies and the use of pluripotent stem cells from people with different forms of leukodystrophy is advancing the understanding of the functional and cellular pathophysiology of these rare diseases.
Keywords: Aicardi Goutières syndrome; Alexander disease; Astroglial leukodystrophies; Canavan disease; Krabbe disease; Merzbacher disease; Microglial leukodystrophies; Nasu-Hakola disease; Oligodendroglial leukodystrophies; Pelizaeus; Vanishing white matter disease.
© 2025. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Neuroglia in leukodystrophies.Handb Clin Neurol. 2025;210:159-175. doi: 10.1016/B978-0-443-19102-2.00032-6. Handb Clin Neurol. 2025. PMID: 40148043 Review.
-
An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.Expert Rev Neurother. 2020 Jan;20(1):65-84. doi: 10.1080/14737175.2020.1699060. Epub 2019 Dec 12. Expert Rev Neurother. 2020. PMID: 31829048 Review.
-
Astroglia in Leukodystrophies.Adv Exp Med Biol. 2019;1175:199-225. doi: 10.1007/978-981-13-9913-8_9. Adv Exp Med Biol. 2019. PMID: 31583590 Review.
-
Inherited white matter disorders: Hypomyelination (myelin disorders).Handb Clin Neurol. 2024;204:197-223. doi: 10.1016/B978-0-323-99209-1.00014-4. Handb Clin Neurol. 2024. PMID: 39322379 Review.
-
Glial cells in the driver seat of leukodystrophy pathogenesis.Neurobiol Dis. 2020 Dec;146:105087. doi: 10.1016/j.nbd.2020.105087. Epub 2020 Sep 23. Neurobiol Dis. 2020. PMID: 32977022 Review.
References
-
- Akwa, Y., Hassett, D. E., Eloranta, M. L., Sandberg, K., Masliah, E., Powell, H., Whitton, J. L., Bloom, F. E., & Campbell, I. L. (1998). Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. Journal of Immunology, 161, 5016–5026. - DOI
-
- Alonso-Gardon, M., Elorza-Vidal, X., Castellanos, A., La Sala, G., Armand-Ugon, M., Gilbert, A., Di Pietro, C., Pla-Casillanis, A., Ciruela, F., Gasull, X., et al. (2021). Identification of the GlialCAM interactome: the G protein-coupled receptors GPRC5B and GPR37L1 modulate megalencephalic leukoencephalopathy proteins. Human Molecular Genetics, 30, 1649–1665. - PubMed - PMC - DOI
Publication types
MeSH terms
LinkOut - more resources
Miscellaneous